Table 4. Patient demographics and background characteristics.

	Patients with APA.
	Number (%) patients
Factors	Total	platelet transfusion
		+	−
	66 (100)	6 (9.1)	60 (90.9)	P-value
Male	47 (71.2)	5 (83)	42 (70)	0.49
Complication
Chronic Renal Failure	11 (16.7)	0	11(18.3)	0.25
Diabetes mellitus	16 (24.2)	1 (16.7)	15 (25.0)	0.65
Hypertension	62 (93.9)	5 (83.3)	57 (95.0)	0.32
Liver cirrhosis	1 (1.5)	0	1(1.7)	0.75
Coronary heart disease	15 (22.7)	3 (50)	12 (20)	0.09
Transient ischemic attack	14 (21.2)	1(16.7)	13 (21.7)	1.00
Atrial fibrillation	6 (9.1)	1(16.7)	5 (8.3)	0.45
Deep vein thrombosis	0	0	0	N.D.
Valvular disease of heart	1 (1.5)	0	1 (1.7)	1.00
Warfarin	10 (15.2)	2 (33.3)	8 (13.3)	0.33
Location
Subcortical	13 (19.7)	1 (25)	12 (20.0)	1.00
Supratentorial	34(51.5)	2 (33.3)	32 (53.3)	0.42
Infratentorial	19 (28.8)	3 (50)	16 (26.7)	0.34
IVH	17 (25.8)	2 (33.3)	15 (25.0)	0.64
Operation	5 (7.6)	3 (50)	2 (3.3)	0.0001
Transfusion
Platelet	6 (9.1)	6 (100)	60 (90.9)	0.64
Fresh frozen plasma	5 (7.6)	2 (33.3)	3 (5.0)	0.06
Disease progression	32 (49.2)	3 (50)	29 (49.2)	1.00
Outcome at 7th day
Died	30 (45.5)	0	30 (50)	0.03
Outcome at 90th day				0.008
Died	31 (47)	0	31 (77.5)
Alive (independent)	6 (14)	2 (66.7)	4 (10)
Alive (dependent)	6 (14)	1 (33.3)	5 (12.5)
Lost of follow up	23 (34.8)	3 (50)	20 (33.3)

Numerical variates are given as N (%) and are compared with the

chi-square test or Fisher's exact test, as appropriate.

N.D.:not done.

ICH: intracerebral hemorrhage. APA: anti-platelet agents.

IVH: intraventricular hemorrhage.